Table 1. KPC34 is active against ALL in vitro in the nanomolar range.
Cell Line | Properties | KPC34 IC50 (95% CI) |
---|---|---|
B6-ALL (Ph+) | Murine B ALL, BCR-ABL, ARF- | 10.36 nM (8.448–12.7) |
SUPB15 (Ph+) | Human B cell ALL, BCR-ABL | 7.39 nM (6.25–8.73) |
Jurkat | Human T cell ALL | 27.94 nM (22.88–34.12) |
MOLT4 | Human T cell ALL, heterozygous p53 (point missense mutation) | 42.71 nM (32.59–55.96) |
CCRF-CEM | Human T cell lymphoblastic ALL, compound heterozygote with two p53 point mutations | 175.6 nM (146.8–210.0) |